Литература
1. Ford E., Ajani U., Groft J. et al. Explaining the decrease in U.S. Deaths from coronary disease, 1980-2000 // N. Engl. J. Med. 2007. Vol. 356. P. 2388-2398. doi: 10.1056/NEJMsa053935.
2. Levy D., Garrison R., Savage D. et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study // N. Engl. J. Med. 1990. Vol. 322. P. 15611566. doi: 10.1056/NEJM199005313222203.
3. Galderisi M. Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient // Am. J. Hypertens. 2011. Vol. 24, N 5. P. 507-517. URL: https://doi.org/10.1038/ajh.2010.235.
4. Joffres M., Falaschetti E., Gillespie C. et al. Hypertension prevalence, awareness, treatment and control in national surveys from England,the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study // BMJ. 2013. Vol. 3. Article ID e003423. doi: 10.1136/bmjopen-2013-003423.
5. Malachias M. et al. 7th Brazilian Guideline of Arterial Hypertension: Chapter 1 - concept, epidemiology and primary prevention // Arq. Bras. Cardiol. 2016. Vol. 107, N 3. P. 1-6. doi: 10.5935/abc.20160151.
6. Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования эссе // Кардиоваскуляр. тер. и профилактика. 2014. Т. 13, № 4. С. 4-14. URL: https://doi.org/10.15829/1728-8800-2014-4-4-14.
7. Hurst T., Burke R., Wissner E. et al. Incidence of subclinical atherosclerosis as a marker of cardiovascular risk in retired professional football players // Am. J. Cardiol. 2010. Vol. 105, N 8. P. 1107-1111. doi: https://doi.org/10.1016/j.amjcard.2009.12.012.
8. Laukkanen J.A., Khan H., Kurl S. et al. Left ventricular mass and the risk of sudden cardiac death: a population-based study // J. Am. Heart Assoc. 2014. Vol. 3, N 6. Article ID e001285. doi: 10.1161/ JAHA.114.001285.
9. Laukkanen J.A., Jennings J.R., Kauhanen J. et al. Relation of systemic blood pressure to sudden cardiac death // Am. J. Cardiol. 2012. Vol. 110, N 3. P. 378-382. doi: https://doi.org/10.1016/j.amjcard.2012.03.035.
10. Black H.R., Sica D., Ferdinand K., White W.B. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 6: Hypertension // Circulation. 2015. Vol. 132, N 22. P. e298-e302. doi: 10.1161/ CIR.0000000000000242.
11. Le V., Mitiku T., Sungar G. et al. The blood pressure response to dynamic exercise testing: a systematic review // Prog. Cardiovasc. Dis. 2008. Vol. 51, N 2. P. 135-160. URL: https://doi.org/10.1016/j.pcad.2008.07.001.
12. Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension // Eur. Heart J. 2018. Vol. 39, N 33. P. 3021-3104. URL: https://doi.org/10.1093/eurheartj/ehy339.
13. Holmqvist L., Mortensen L., Kanckos C. et al. Exercise blood pressure and the risk of future hypertension // J. Hum. Hypertens. 2012. Vol. 26. P. 691-695. URL: https://doi.org/10.1038/jhh.2011.99.
14. Agnoletti D. The aerobic exercise training in hypertension: a matter of baking ingredients // J. Hypertens. 2018. Vol. 36, N 8. P. 1651-1653. doi: 10.1097/HJH.0000000000001776.
15. Elley C., Arroll B. Review: aerobic exercise reduces systolic and diastolic blood pressure in adults // BMJ Evid. Based Med. 2002. Vol. 7, N 6. URL: http://dx.doi.org/10.1136/ebm.7.6.170.
16. Predel H. Marathon run: cardiovascular adaptation and cardiovascular risk // Eur. Heart J. 2014. Vol. 35, N 44. P. 3091-3098. URL: https://doi.org/10.1093/eurheartj/eht502.
17. Kodama S., Tanaka S., Saito K. et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a metaanalysis // Arch. Intern. Med. 2007. Vol. 167, N 10. P. 999-1008. doi: 10.1001/archinte.167.10.999.
18. Diaz K.M., Shimbo D. Physical activity and the prevention of hypertension // Curr. Hypertens. Rep. 2013. Vol. 15, N 6. P. 659-668. doi: 10.1007/s11906-013-0386-8.
19. Florido R., Zhao D., Guallar D. et al. Associations of change in physical activity levels with changes in cardiac structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA) // Circulation. 2018. Vol. 136. Article ID A14655.
20. Tikkanen E., Gustafsson S., Ingelsson E. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK Biobank Study // Circulation. 2018. Vol. 137, N 24. P. 2583-2591. doi: 10.1161/CIRCULATIONAHA.117.032432.
21. Lee I.M., Shiroma E.J., Evenson K.R., Kamada M. et al. Accelerometer-measured physical activity and sedentary behavior in relation to all-cause mortality: The Women’s Health Study // Circulation. 2017. Vol. 137, N 2. P. 203-205. doi: 10.1161/CIRCULATIONAHA.117.031300.
22. Bird S.R., Hawley J.A. Update on the effects of physical activity on insulin sensitivity in humans // BMJ Open Sport Exerc. Med. 2017. Vol. 2. Article ID e000143. doi: 10.1136/bmjsem-2016-000143.
23. Trine M. et al. Interaction of physical activity and body mass index on mortality in coronary heart disease: data from the Nord-Trondelag Health Study // Am. J. Med. 2017. Vol. 130, N 8. P. 949-957. doi: 10.1016/j.amjmed.2017.01.043.
24. Ven P.C., Wai J.P., Tsai M.K. et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study // Lancet. 2011. Vol. 378, N 9798. P. 1244-1253. doi: 10.1016 / S0140-6 7 36 (11) 60749-6.
25. McMullen C.W., Harrast M.A., Baggish A.L. Optimal running dose and cardiovascular risk // Curr. Sports Med. Rep. 2018. Vol. 17, N 6. P. 192-198. doi: 10.1249/JSR.0000000000000491.
26. Black H.R., Sica D., Ferdinand K., White W.B. AHA/ACC scientific statement. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology // J. Am. Coll. Cardiol. 2015. Vol. 66, N 21. P. 2393-2397. URL: https://doi.org/10.1016/j.jacc.2015.09.038.
27. Borjesson M., Onerup A., Lundqvist S., Dahlof B. Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs // Br. J. Sports Med. 2015. Vol. 50, N 6. URL: http://dx.doi.org/10.1136/bjsports-2015-095786.
28. Arem H., Moore S.C., Patel A. et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship // JAMA Intern. Med. 2015. Vol. 175, N 6. P. 959-967. doi: 10.1001/jamainternmed.2015.0533.
29. Global Recommendations on Physical Activity for Health 2010. URL: https://www.who.int/dietphysicalactivity/factsheet_recommendations/en/
30. Hegde S.M., Solomon S.D. Influence of physical activity on hypertension and cardiac structure and function // Curr. Hypertens. Rep. 2015. Vol. 17. P. 77. URL: https://doi.org/10.1007/s11906-015-0588-3.
31. Oja P., Kelly P., Pedisic Z. et al. Associations of specific types of sports and exercise with all-cause and cardiovascular-disease mortality: a cohort study of 80 306 British adults // Br. J. Sports Med. 2017. Vol. 51. P. 812-817. doi: 10.1136/bjsports-2016-096822.
32. Gerche A., Burns A.T., Mooney D.J. et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes // Eur. Heart J. 2012. Vol. 33, N 8. P. 998-1006. URL: https://doi.org/10.1093/eurheartj/ehr397.
33. O’Keefe J.H., Patil H.R., Lavie C.J. et al. Potential adverse cardiovascular effects from excessive endurance exercise // Mayo Clin. Proc. 2012. Vol. 87, N 6. P. 587-595. doi: 10.1016/j.mayocp.2012.04.005.
34. Feairheller D.L., Aichele K.R., Oakman J.E. et al. Vascular health in American football players: cardiovascular risk increased in Division III players // Int. J. Vasc. Med. 2016. Vol. 2016. Article ID 6851256. doi: 10.1155/2016/6851256.
35. Kim J.H., Malhotra R., Chiampas G., d’Hemecourt P. et al. Cardiac arrest during long-distance running races // N. Engl. J. Med. 2012. Vol. 366. P. 130-140. doi: 10.1056/NEJMoa1106468.
36. Berge H.M., Isern C.B., Berge E. Blood pressure and hypertension in athletes: a systematic review // Br. J. Sports Med. 2015. Vol. 49. P. 716-723. doi: 10.1136/bjsports-2014-093976.
37. Caselli S., Sequi A/V., Lemme E. et al. Prevalence and management of systemic hypertension in athletes // Am. J. Cardiol. 2017. Vol. 119, N 10. P. 1616-1622. doi: https://doi.Org/10.1016/j.amjcard.2017.02.011.
38. Bobrie G., Clerson P., Menard J. et al. Masked hypertension: a systematic review // J. Hypertens. 2008. Vol. 26, N 9. P. 1715-1725. doi: 10.1097/HJH.0b013e3282fbcedf.
39. Trachsel L.D., Carlen F., Brugger N. et al. Masked hypertension and cardiac remodeling in middle-aged endurance athletes // J. Hypertens. 2015. Vol. 33. P. 1276-1283. doi: 10.1097/ HJH.0000000000000558.
40. Morrison B.N., McKinney J., Isserow S. et al. Assessment of cardiovascular risk and preparticipation screening protocols in masters athletes: the Masters Athlete Screening Study (MASS): across-sectional study // BMJ Open Sport Exerc. Med. 2018. Vol. 4. Article ID e000370. doi: 10.1136/bmjsem-2018-000370.
41. Shapero K., Deluca J., Contursi M. et al. Cardiovascular risk and disease among masters endurance athletes: insights from the Boston MASTER (Masters Athletes Survey To Evaluate Risk) Initiative // Sports Med. Open. 2016. Vol. 2. P. 29. URL: https://doi.org/10.1186/s40798-016-0053-0.
42. De Matos L., Calderia N., Perlingeiro P. et al. Cardiovascular risk and clinical factors in athletes: 10 years of evaluation // Med. Sci. Sports Exerc. 2011. Vol. 43, N 6. P. 943-950. doi: 10.1249/ MSS.0b013e318203d5cb.
43. George K., Spence A., Naylor L.H. et al. Cardiac adaptation to acute and chronic participation in endurance sports // Heart. 2011. Vol. 97, N 24. URL: http://dx.doi.org/10.1136/heartjnl-2011-300536.
44. Weiner R.B., Baggish A.L. Exercise-induced cardiac remodeling // Prog. Cardiovasc. Dis. 2012. Vol. 54, N 5. P. 380-386. URL: https://doi.org/10.1016/j.pcad.2012.01.006.
45. Banfi G., Colombini A., Lombardi G., Lubkowska A. Metabolic markers in sports medicine // Adv. Clin. Chem. 2012. Vol. 56. P. 1-54. URL: https://doi.org/10.1016/B978-0-12-394317-0.00015-7.
46. Pluim B.M., Zwinderman A.H., van der Laarse A., van der Wall E.E. The athlete’s heart. A meta-analysis of cardiac structure and function // Circulation. 2000. Vol. 101, N 3. P. 336-344.
47. Lovic D., Narayan P., Pittaras A. et al. Left ventricular hypertrophy in athletes and hypertensive patients // J. Clin. Hypertens. 2017. Vol. 19, N 4. URL: https://doi.org/10.1111/jch.12977.
48. Cornelissen V.A., Smart N.A. Exercise training for blood pressure: a systematic review and meta-analysis // J. Am. Heart Assoc. 2013. Vol. 2, N 1. Article ID e004473. doi: 10.1161/JAHA.112.004473.
49. Kreso A., Barakovic F., Medjedovic S. et al. Electrocardiographic and echocardiographic imaging of the heart of athletes and patients with hypertension // Med. Arch. 2015. Vol. 69, N 5. P. 319-322. doi: 10.5455/medarh.2015.69.319-322.
50. Wilhelm M., Roten L., Tanner H. et al. Gender differences of atrial and ventricular remodeling and autonomic tone in nonelite athletes // Am. J. Cardiol. 2011. Vol. 108, N 10. P. 1489-1495. doi: https://doi.org/10.1016/j.amjcard.2011.06.073.
51. Tsioufis C. "Hearts that strain": distinguishing athlete’s heart from hypertensive disease in the echo lab and beyond // Hellenic J. Cardiol. 2018. Vol. 59, N 3. P. 189-191. URL: https://doi.org/10.1016/j.hjc.2018.06.006.
52. Kjaer A., Meyer C., Wachtell K. et al. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy // Am. J. Cardiol. 2005. Vol. 96, N 12. P. 1692-1698.
53. Niebauer J., Borjesson M., Carre F. et al. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC) // Eur. Heart J. 2018. Vol. 39, N 40. P. 3664-3671. doi: 10.1093/eurheartj/ehy511.
54. Kjeldsen S., Feldman R.D., Lisheng L. et al. Updated national and international hypertension guidelines: a review of current recommendations // Drugs. 2014. Vol. 74, N 17. P. 2033-2051. doi: 10.1007/s40265-014-0306-5.
55. Caselli S., Vaquer Segui A., Quattrini F. et al. Upper normal values of blood pressure response to exercise in Olympic athletes // Am. Heart J. 2016. Vol. 177. P. 120-128. doi: 10.1016/j.ahj.2016.04.020.
56. Lang R.M., Badano L.P, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // J. Am. Soc. Echocardiogr. 2015. Vol. 28, N 1. P. 1-39. URL: https://doi.org/10.1016/j.echo.2014.10.003.
57. Демидова Н.Ю., Белоусов Ю.В. Эхокардиографические признаки "гипертонического сердца" // Патология кровообращения и кардиохир. 2006. № 4. С. 75-78.
58. Fagard R. Athlete’s heart // Heart. 2003. Vol. 89. P. 14551461.
59. Cuspidi C., Sala C., Negri F. et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies // J. Hum. Hypertens. 2012. Vol. 26. P. 343-349. doi: 10.1038/ jhh.2011.104.
60. Mosley J.D., Levinson R.T., Brittain E.L. et al. Clinical features associated with nascent left ventricular diastolic dysfunction in a population aged 40 to 55 years // Am. J. Cardiol. 2018. Vol. 121, N 12. P. 1552-1557. doi: 10.1016/j.amjcard.2018.02.042.
61. Swierblewska E., Wolf J., Kunicka K. et al. Prevalence and distribution of left ventricular diastolic dysfunction in treated patients with long-lasting hypertension // Blood Press. 2018. Vol. 27, N 6. P. 376-384. doi: 10.1080/08037051.2018.1484661.
62. Williams B., Mancia G., Spiering W. et al., ESC Scientific Document Group; 2018 ESC/ESH Guidelines for the management of arterial hypertension // Eur. Heart J. 2018. Vol. 39, N 33. P. 30213104. URL; https://doi.org/10.1093/eurheartj/ehy339.
63. Asplund C. Treatment of hypertension in athletes: an evidence-based review // Phys. Sportsmed. 2010. Vol. 38, N 1. P. 37-44. doi: 10.3810/psm.2010.04.1760.
64. Schleich K., Smoot M., Ernst M. Hypertension in athletes and active populations // Curr. Hypertens. Rep. 2016. Vol. 18. P. 77. URL: https://doi.org/10.1007/s11906-016-0685-y.
65. Leischik R., Spelsberg N., Niggemann H. et al. Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? // F1000Research. 2014. Vol. 3. P. 105. doi: 10.12688/ f1000research.4001.1.
References
1. Ford E., Ajani U., Groft J., et al. Explaining the decrease in U.S. Deaths from coronary disease, 1980-2000. N Engl J Med. 2007; 356: 2388-98. doi: 10.1056/NEJMsa053935.
2. Levy D., Garrison R., Savage D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322: 1561-6. doi: 10.1056/NEJM199005313222203.
3. Galderisi M. Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient. Am J Hypertens. 2011; 24 (5): 507-17. URL: https://doi.org/10.1038/ajh.2010.235.
4. Joffres M., Falaschetti E., Gillespie C., et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ. 2013; 3: e003423. doi: 10.1136/bmjopen-2013-003423.
5. Malachias M., et al. 7th Brazilian Guideline of Arterial Hypertension: Chapter 1 - concept, epidemiology and primary prevention. Arq Bras Cardiol. 2016; 107 (3): 1-6. doi: 10.5935/ abc.20160151.
6. Boytsov S.A., Balanova Y.A., Shalnova S.A., et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ecce. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2014; 13 (4): 4-14. URL: https://doi.org/10.15829/1728-8800-2014-4-4-14. (in Russian)
7. Hurst T., Burke R., Wissner E., et al. Incidence of subclinical atherosclerosis as a marker of cardiovascular risk in retired professional football players. Am J Cardiol. 2010; 105 (8): 1107-11. doi: https://doi.org/10.1016/j.amjcard.2009.12.012.
8. Laukkanen J.A., Khan H., Kurl S., et al. Left ventricular mass and the risk of sudden cardiac death: a population-based study. J Am Heart Assoc. 2014; 3 (6): e001285. doi: 10.1161/JAHA.114.001285.
9. Laukkanen J.A., Jennings J.R., Kauhanen J., et al. Relation of systemic blood pressure to sudden cardiac death. Am J Cardiol. 2012; 110 (3): 378-82. doi: https://doi.org/10.1016/j.amjcard.2012.03.035.
10. Black H.R., Sica D., Ferdinand K., White W.B. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 6: Hypertension. Circulation. 2015; 132 (22): e298-302. doi: 10.1161/CIR.0000000000000242.
11. Le V., Mitiku T., Sungar G., et al. The blood pressure response to dynamic exercise testing: a systematic review. Prog Cardiovasc Dis. 2008; 51 (2): 135-60. URL: https://doi.org/10.1016/].pcad.2008.07.001.
12. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39 (33): 3021-104. URL: https://doi.org/10.1093/eurheartj/ehy339.
13. Holmqvist L., Mortensen L., Kanckos C., et al. Exercise blood pressure and the risk of future hypertension. J Hum Hypertens. 2012; 26: 691-5. URL: https://doi.org/10.1038/jhh.2011.99.
14. Agnoletti D. The aerobic exercise training in hypertension: a matter of baking ingredients. J Hypertens. 2018; 36 (8): 1651-3. doi: 10.1097/HJH.0000000000001776.
15. Elley C., Arroll B. Review: aerobic exercise reduces systolic and diastolic blood pressure in adults. BMJ Evid Based Med. 2002; 7 (6). URL: http://dx.doi.org/10.1136/ebm.7.6.170.
16. Predel H. Marathon run: cardiovascular adaptation and cardiovascular risk. Eur Heart J. 2014; 35 (44): 3091-8. URL: https://doi.org/10.1093/eurheartj/eht502.
17. Kodama S., Tanaka S., Saito K., et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a metaanalysis. Arch Intern Med. 2007; 167 (10): 999-1008. doi: 10.1001/ archinte.167.10.999.
18. Diaz K.M., Shimbo D. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013; 15 (6): 659-68. doi: 10.1007/s11906-013-0386-8.
19. Florido R., Zhao D., Guallar D., et al. Associations of change in physical activity levels with changes in cardiac structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2018; 136: A14655.
20. Tikkanen E., Gustafsson S., Ingelsson E. Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK Biobank Study. Circulation. 2018; 137 (24): 2583-91. doi: 10.1161/CIRCULATIONAHA.117.032432.
21. Lee I.M., Shiroma E.J., Evenson K.R., Kamada M., et al. Accelerometer-measured physical activity and sedentary behavior in relation to all-cause mortality: The Women’s Health Study. Circulation. 2017; 137 (2): 203-5. doi: 10.1161/CIRCULATI0NAHA.117.031300.
22. Bird S.R., Hawley J.A. Update on the effects of physical activity on insulin sensitivity in humans. BMJ Open Sport Exerc. Med. 2017; 2: e000143. doi: 10.1136/bmjsem-2016-000143.
23. Trine M., et al. Interaction of physical activity and body mass index on mortality in coronary heart disease: data from the Nord-Trondelag Health Study. Am J Med. 2017; 130 (8): 949-57. doi: 10.1016/j.amjmed.2017.01.043.
24. Ven P.C., Wai J.P., Tsai M.K., et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011; 378 (9798): 1244-53. doi: 10.1016/S0140-6 7 36 (11) 60749-6.
25. McMullen C.W., Harrast M.A., Baggish A.L. Optimal running dose and cardiovascular risk. Curr Sports Med Rep. 2018; 17 (6): 1928. doi: 10.1249/JSR.0000000000000491.
26. Black H.R., Sica D., Ferdinand K., White W.B. AHA/ACC scientific statement. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 2015; 66 (21): 2393-7. URL: https://doi.org/10.1016/j.jacc.2015.09.038.
27. Borjesson M., Onerup A., Lundqvist S., Dahlof B. Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs. Br J Sports Med. 2015; 50 (6). URL: http://dx.doi.org/10.1136/bjsports-2015-095786.
28. Arem H., Moore S.C., Patel A., et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015; 175 (6): 959-67. doi: 10.1001/jamainternmed.2015.0533.
29. Global Recommendations on Physical Activity for Health 2010. URL: https://www.who.int/dietphysicalactivity/factsheet_recommendations/en/
30. Hegde S.M., Solomon S.D. Influence of physical activity on hypertension and cardiac structure and function. Curr Hypertens Rep. 2015; 17: 77. URL: https://doi.org/10.1007/s11906-015-0588-3.
31. Oja P., Kelly P., Pedisic Z., et al. Associations of specific types of sports and exercise with all-cause and cardiovascular-disease mortality: a cohort study of 80 306 British adults. Br J Sports Med. 2017; 51: 812-7. doi: 10.1136/bjsports-2016-096822.
32. Gerche A., Burns A.T., Mooney D.J., et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012; 33 (8): 998-1006. URL: https://doi.org/10.1093/eurheartj/ehr397.
33. O’Keefe J.H., Patil H.R., Lavie C.J., et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012; 87 (6): 587-95. doi: 10.1016/j.mayocp.2012.04.005.
34. Feairheller D.L., Aichele K.R., Oakman J.E., et al. Vascular health in American football players: cardiovascular risk increased in Division III players. Int J Vasc Med. 2016; 2016: 6851256. doi: 10.1155/2016/6851256.
35. Kim J.H., Malhotra R., Chiampas G., d’Hemecourt P., et al. Cardiac arrest during long-distance running races. N Engl J Med. 2012; 366: 130-40. doi: 10.1056/NEJMoa1106468.
36. Berge H.M., Isern C.B., Berge E. Blood pressure and hypertension in athletes: a systematic review. Br J Sports Med. 2015; 49: 716-23. doi: 10.1136/bjsports-2014-093976.
37. Caselli S., Sequi A/V., Lemme E., et al. Prevalence and management of systemic hypertension in athletes. Am J Cardiol. 2017; 119 (10): 1616-22. doi: https://doi.org/10.1016/j.amjcard.2017.02.011.
38. Bobrie G., Clerson P., Menard J., et al. Masked hypertension: a systematic review. J Hypertens. 2008; 26 (9): 1715-25. doi: 10.1097/ HJH.0b013e3282fbcedf.
39. Trachsel L.D., Carlen F., Brugger N., et al. Masked hypertension and cardiac remodeling in middle-aged endurance athletes. J Hypertens. 2015; 33: 1276-83. doi: 10.1097/HJH.0000000000000558.
40. Morrison B.N., McKinney J., Isserow S., et al. Assessment of cardiovascular risk and preparticipation screening protocols in masters athletes: the Masters Athlete Screening Study (MASS): across-sectional study. BMJ Open Sport Exerc. Med. 2018; 4: e000370. doi: 10.1136/bmjsem-2018-000370.
41. Shapero K., Deluca J., Contursi M., et al. Cardiovascular risk and disease among masters endurance athletes: insights from the Boston MASTER (Masters Athletes Survey To Evaluate Risk) Initiative. Sports Med Open. 2016; 2: 29. URL: https://doi.org/10.1186/s40798-016-0053-0.
42. De Matos L., Calderia N., Perlingeiro P., et al. Cardiovascular risk and clinical factors in athletes: 10 years of evaluation. Med Sci Sports Exerc. 2011; 43 (6): 943-50. doi: 10.1249/MSS.0b013e318203d5cb.
43. George K., Spence A., Naylor L.H., et al. Cardiac adaptation to acute and chronic participation in endurance sports. Heart. 2011; 97 (24). URL: http://dx.doi.org/10.1136/heartjnl-2011-300536.
44. Weiner R.B., Baggish A.L. Exercise-induced cardiac remodeling. Prog Cardiovasc Dis. 2012; 54 (5): 380-6. URL: https://doi.org/10.1016/j.pcad.2012.01.006.
45. Banfi G., Colombini A., Lombardi G., Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem. 2012; 56: 1-54. URL: https://doi.org/10.1016/B978-0-12-394317-0.00015-7.
46. Pluim B.M., Zwinderman A.H., van der Laarse A., van der Wall E.E. The athlete’s heart. A meta-analysis of cardiac structure and function. Circulation. 2000; 101 (3): 336-44.
47. Lovic D., Narayan P., Pittaras A., et al. Left ventricular hypertrophy in athletes and hypertensive patients. J Clin Hypertens. 2017; 19 (4). URL: https://doi.org/10.1111/jch.12977.
48. Cornelissen V.A., Smart N.A. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013; 2 (1): e004473. doi: 10.1161/JAHA.112.004473.
49. Kreso A., Barakovic F., Medjedovic S., et al. Electrocardiographic and echocardiographic imaging of the heart of athletes and patients with hypertension. Med Arch. 2015; 69 (5): 319-22. doi: 10.5455/medarh.2015.69.319-322.
50. Wilhelm M., Roten L., Tanner H., et al. Gender differences of atrial and ventricular remodeling and autonomic tone in nonelite athletes. Am J Cardiol. 2011; 108 (10): 1489-95. doi: https://doi.org/10.1016/j.amjcard.2011.06.073.
51. Tsioufis C. "Hearts that strain": distinguishing athlete’s heart from hypertensive disease in the echo lab and beyond. Hellenic J Cardiol. 2018; 59 (3): 189-91. URL: https://doi.org/10.1016/].hjc.2018.06.006.
52. Kjaer A., Meyer C., Wachtell K., et al. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy. Am J Cardiol. 2005; 96 (12): 1692-8.
53. Niebauer J., Borjesson M., Carre F., et al. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2018; 39 (40): 3664-71. doi: 10.1093/eurheartj/ehy511.
54. Kjeldsen S., Feldman R.D., Lisheng L., et al. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014; 74 (17): 2033-51. doi: 10.1007/ s40265-014-0306-5.
55. Caselli S., Vaquer Segui A., Quattrini F., et al. Upper normal values of blood pressure response to exercise in Olympic athletes. Am Heart J. 2016; 177: 120-8. doi: 10.1016/j.ahj.2016.04.020.
56. Lang R.M., Badano L.P., Mor-Avi V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28 (1): 1-39. URL: https://doi.org/10.1016Zj.echo.2014.10.003.
57. Demidova N.Y., Belousov Y.V. Echocardiographic signs of "hypertensive heart". Patologiya krovoobrashcheniya i kardiokhirurgiya [Pathology of Blood Circulation and Cardiac Surgery]. 2006; (4): 75-8. (in Russian).
58. Fagard R. Athlete’s heart. Heart. 2003; 89: 1455-61.
59. Cuspidi C., Sala C., Negri F., et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012; 26: 343-9. doi: 10.1038/jhh.2011.104.
60. Mosley J.D., Levinson R.T., Brittain E.L., et al. Clinical features associated with nascent left ventricular diastolic dysfunction in a population aged 40 to 55 years. Am J Cardiol. 2018; 121 (12): 1552-7. doi: 10.1016/j.amjcard.2018.02.042.
61. Swierblewska E., Wolf J., Kunicka K., et al. Prevalence and distribution of left ventricular diastolic dysfunction in treated patients with long-lasting hypertension. Blood Press. 2018; 27 (6): 376-84. doi: 10.1080/08037051.2018.1484661.
62. Williams B., Mancia G., Spiering W., et al. ESC Scientific Document Group; 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39 (33): 3021-104. URL: https://doi.org/10.1093/eurheartj/ehy339.
63. Asplund C. Treatment of hypertension in athletes: an evidence-based review. Phys Sportsmed. 2010; 38 (1): 37-44. doi: 10.3810/ psm.2010.04.1760.
64. Schleich K., Smoot M., Ernst M. Hypertension in athletes and active populations. Curr Hypertens Rep. 2016; 18: 77. URL: https://doi.org/10.1007/s11906-016-0685-y.
65. Leischik R., Spelsberg N., Niggemann H., et al. Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? F1000Research. 2014; 3: 105. doi: 10.12688/f1000research.4001.1.